ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia

ClinicalTrials.gov ID: NCT03990363

Public ClinicalTrials.gov record NCT03990363. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 2:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Multicentre, Randomised, Double-blind, Placebo-controlled Study of Verinurad and Allopurinol in Patients With Chronic KIdney Disease and Hyperuricaemia

Study identification

NCT ID
NCT03990363
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
861 participants

Conditions and interventions

Interventions

  • Allopurinol Drug
  • Placebo for Allopurinol Drug
  • Placebo for Verinurad Drug
  • Verinurad Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 22, 2019
Primary completion
Nov 21, 2021
Completion
Nov 21, 2021
Last update posted
Mar 1, 2023

2019 – 2021

United States locations

U.S. sites
54
U.S. states
20
U.S. cities
48
Facility City State ZIP Site status
Research Site Huntsville Alabama 35805
Research Site Bakersfield California 93309
Research Site Canyon Country California 91351
Research Site Laguna Hills California 92653
Research Site Long Beach California 90807
Research Site Northridge California 91324
Research Site Orange California 92868
Research Site Thousand Oaks California 91360
Research Site Vacaville California 95687
Research Site Victorville California 92395
Research Site Denver Colorado 80230
Research Site Bloomfield Connecticut 06002
Research Site Washington D.C. District of Columbia 20037
Research Site Altamonte Springs Florida 32701
Research Site Hialeah Florida 33012
Research Site Jacksonville Florida 32204
Research Site Lauderdale Lakes Florida 33313
Research Site Miami Florida 33015
Research Site Miami Florida 33126-2956
Research Site Miami Florida 33165
Research Site Miami Lakes Florida 33014
Research Site Ocala Florida 34471
Research Site Ocoee Florida 34761
Research Site Pembroke Pines Florida 33026
Research Site Port Charlotte Florida 33952
Research Site Lawrenceville Georgia 30046
Research Site Wauconda Illinois 60084
Research Site Paducah Kentucky 42003
Research Site Takoma Park Maryland 20912
Research Site Flint Michigan 48504
Research Site Flint Michigan 48532
Research Site Saint Clair Shores Michigan 48081
Research Site Minneapolis Minnesota 55404
Research Site Jamaica New York 11432
Research Site The Bronx New York 10461
Research Site Asheville North Carolina 28801
Research Site Asheville North Carolina 28803
Research Site Rocky Mount North Carolina 27804
Research Site Wilmington North Carolina 28401
Research Site Winston-Salem North Carolina 27103
Research Site Philadelphia Pennsylvania 19107
Research Site Orangeburg South Carolina 29118
Research Site Knoxville Tennessee 37923
Research Site Arlington Texas 76015
Research Site El Paso Texas 79935
Research Site Houston Texas 77004
Research Site Lampasas Texas 76550
Research Site Lewisville Texas 75057
Research Site Pearland Texas 77584
Research Site San Antonio Texas 78212
Research Site San Antonio Texas 78231
Research Site San Antonio Texas 78258
Research Site Alexandria Virginia 22304
Research Site Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 111 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03990363, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 1, 2023 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03990363 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →